Vera Therapeutics, Inc.
VERA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001831828
In the last 90 days, Vera Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 219 institutions reported holding it in 13F filings for Q2 2026, worth $3.34B in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Vera Therapeutics, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 55 | 59 | +4 |
| Shares | 21.5M | 21.3M | −207.2K (−1.0%) |
| Value | $459.0M | $412.8M | −$46.3M (−10.1%) |
New holders (10)
Institutions that held Vera Therapeutics, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Logos Global Management LP | 285,000 | $5.51M | 0.65% |
| Walleye Capital LLC | 229,204 | $4.44M | 0.10% |
| Pura Vida Investments, LLC | 35,372 | $684.4K | 0.11% |
| Moore Capital Management, LP | 25,000 | $483.8K | 0.01% |
| Renaissance Technologies LLC | 24,900 | $482.0K | 0.00% |
| Jump Financial, LLC | 17,600 | $340.6K | 0.02% |
| Two Sigma Investments, LP | 17,017 | $329.3K | 0.00% |
| Dimensional Fund Advisors LP | 11,498 | $223.0K | 0.00% |
| Walleye Trading LLC | 10,945 | $211.8K | 0.01% |
| Nisa Investment Advisors, LLC | 17 | $0 | 0.00% |
Sold out (6)
Institutions that held Vera Therapeutics, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Ra Capital Management, L.P. | 1,578,820 | $33.6M |
| Point72 Asset Management, L.P. | 121,000 | $2.58M |
| BNP Paribas Arbitrage, SA | 5,183 | $110.5K |
| Cubist Systematic Strategies, LLC | 5,000 | $107.0K |
| STRS Ohio | 1,600 | $34.0K |
| Wells Fargo & Company | 231 | $5.00K |